Chemomab Therapeutics (CMMB) Short Interest Ratio & Short Volume $1.37 +0.02 (+1.48%) Closing price 03:58 PM EasternExtended Trading$1.36 -0.01 (-0.36%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemomab Therapeutics Short Interest DataChemomab Therapeutics (CMMB) has a short interest of 134,700 shares, representing 0.81% of the float (the number of shares available for trading by the public). This marks a -47.36% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 301,859 shares to cover all short positions.Current Short Interest134,700 sharesPrevious Short Interest255,900 sharesChange Vs. Previous Month-47.36%Dollar Volume Sold Short$162,987.00Short Interest Ratio0.4 Days to CoverLast Record DateApril 15, 2025Outstanding Shares14,359,000 sharesFloat Size16,570,000 sharesShort Percent of Float0.81%Today's Trading Volume55,583 sharesAverage Trading Volume301,859 sharesToday's Volume Vs. Average18% Short Selling Chemomab Therapeutics? Sign up to receive the latest short interest report for Chemomab Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMMB Short Interest Over TimeCMMB Days to Cover Over TimeCMMB Percentage of Float Shorted Over Time Chemomab Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025134,700 shares $162,987.00 -47.4%0.8%0.4 $1.21 3/31/2025255,900 shares $278,931.00 -5.1%1.5%0.7 $1.09 3/15/2025269,500 shares $379,995.00 -30.9%1.6%0.8 $1.41 2/28/2025389,900 shares $655,032.00 +1,230.7%2.4%1.2 $1.68 2/15/202529,300 shares $57,428.00 -60.9%0.2%0.1 $1.96 1/31/202574,900 shares $152,796.00 -0.4%0.5%0.7 $2.04 1/15/202575,200 shares $148,144.00 +1.9%0.5%0.7 $1.97 12/31/202473,800 shares $133,578.00 -33.9%0.5%0.6 $1.81 12/15/2024111,600 shares $176,328.00 +8.2%0.7%0.9 $1.58 11/30/2024103,100 shares $187,642.00 -25.4%0.6%0.7 $1.82 Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024138,200 shares $231,485.00 -15.2%0.8%0.7 $1.68 10/31/2024162,900 shares $231,318.00 +74.0%1.3%0.7 $1.42 10/15/202493,600 shares $122,616.00 +29.1%0.7%0.3 $1.31 9/30/202472,500 shares $113,825.00 +23.7%0.6%0.3 $1.57 9/15/202458,600 shares $104,601.00 -72.8%0.5%0.2 $1.79 8/31/2024215,200 shares $434,704.00 +1,003.6%1.8%1 $2.02 8/15/202419,500 shares $21,060.00 -75.0%0.2%0.1 $1.08 7/31/202478,000 shares $91,260.00 -25.7%0.7%0.6 $1.17 7/15/2024105,000 shares $114,450.00 +4.5%0.9%1 $1.09 6/30/2024100,500 shares $91,706.15 +0.8%0.8%1 $0.91 6/15/202499,700 shares $112,661.00 +62.1%0.8%1 $1.13 5/31/202461,500 shares $65,805.00 -41.0%0.5%0.6 $1.07 5/15/2024104,200 shares $90,862.40 -10.7%0.9%1.1 $0.87 4/30/2024116,700 shares $81,690.00 -25.1%1.0%0.5 $0.70 4/15/2024155,800 shares $113,734.00 -29.8%1.3%0.7 $0.73 3/31/2024221,900 shares $172,860.10 +14.3%1.9%1 $0.78 3/15/2024194,200 shares $155,224.06 -20.5%1.8%0.8 $0.80 2/29/2024244,300 shares $167,345.50 +549.7%2.5%0.9 $0.69 2/15/202437,600 shares $22,936.00 +15.7%0.4%0.1 $0.61 1/31/202432,500 shares $18,752.50 +5.5%0.3%0 $0.58 1/15/202430,800 shares $17,217.20 -23.8%0.3%0 $0.56 12/31/202340,400 shares $20,604.00 +125.7%0.3%0 $0.51 12/15/202317,900 shares $9,039.50 -84.8%0.1%0 $0.51 11/30/2023117,900 shares $63,548.10 +287.8%1.2%0.1 $0.54 11/15/202330,400 shares $24,836.80 -5.6%0.3%0 $0.82 10/31/202332,200 shares $23,583.28 -28.1%0.3%1.7 $0.73 10/15/202344,800 shares $39,827.20 -2.6%0.5%2.4 $0.89 9/30/202346,000 shares $41,170.00 +23.0%0.5%2 $0.90 9/15/202337,400 shares $40,766.00 -9.2%0.4%0.7 $1.09 8/31/202341,200 shares $45,732.00 -8.9%0.4%0.2 $1.11The next market Nvidia is positioned to dominate … (Ad)Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.To see a live demonstration with one of these robots, simply click here. 8/15/202345,200 shares $50,624.00 -19.6%0.5%0.3 $1.12 7/31/202356,200 shares $71,936.00 -43.4%0.5%0.3 $1.28 7/15/202399,200 shares $139,872.00 +6.6%0.9%0.6 $1.41 6/30/202393,100 shares $121,961.00 -69.1%1.1%0.5 $1.31 6/15/2023301,700 shares $512,890.00 -7.6%3.4%1.8 $1.70 5/31/2023326,500 shares $512,605.00 -22.8%3.7%11.9 $1.57 5/15/2023422,900 shares $689,327.00 -7.3%4.8%5.7 $1.63 4/30/2023456,300 shares $679,887.00 -11.8%4.9%1 $1.49 4/15/2023517,400 shares $838,188.00 +1.5%5.6%1.1 $1.62 3/31/2023510,000 shares $810,900.00 -15.7%5.5%1.1 $1.59 3/15/2023605,200 shares $913,852.00 -8.2%7.1%0.7 $1.51 2/28/2023658,900 shares $1.02 million +457.9%7.7%0.8 $1.55 2/15/2023118,100 shares $237,381.00 +3.9%1.4%0.1 $2.01 1/31/2023113,700 shares $261,510.00 -24.8%1.4%0.3 $2.30 1/15/2023151,200 shares $341,712.00 +269.7%1.8%0.3 $2.26 12/30/202240,900 shares $130,880.00 -19.7%0.5%0.1 $3.20 12/15/202250,900 shares $109,435.00 +155.8%0.6%1 $2.15 11/30/202219,900 shares $41,790.00 -69.9%0.3%0.5 $2.10 11/15/202266,100 shares $134,844.00 +66,000.0%0.8%1.6 $2.04 10/31/2022100 shares $204.00 No ChangeN/A0 $2.04 10/15/2022100 shares $200.00 -93.3%N/A0 $2.00 9/30/20221,500 shares $3,735.00 -83.0%0.0%0 $2.49 9/15/20228,800 shares $28,776.00 -36.7%0.1%0.2 $3.27 8/31/202213,900 shares $45,592.00 -42.3%0.2%0.3 $3.28 8/15/202224,100 shares $94,954.00 +230.1%0.3%0.5 $3.94 7/31/20227,300 shares $22,265.00 +49.0%0.1%0.2 $3.05 7/15/20224,900 shares $15,484.00 -78.0%0.1%0.1 $3.16 6/30/202222,300 shares $82,510.00 +147.8%0.3%0.6 $3.70 6/15/20229,000 shares $31,230.00 -14.3%0.1%0.2 $3.47 5/31/202210,500 shares $32,340.00 +34.6%0.1%0.2 $3.08 5/15/20227,800 shares $21,372.00 -34.5%0.1%0.1 $2.74 4/30/202211,900 shares $37,485.00 +205.1%0.2%0.2 $3.15 4/15/20223,900 shares $14,859.00 -76.8%0.1%0.1 $3.81 3/31/202216,800 shares $80,640.00 -32.5%0.2%0.2 $4.80 3/15/202224,900 shares $98,853.00 -26.1%N/A0.2 $3.97 2/28/202233,700 shares $146,258.00 +6.3%0.4%0.3 $4.34 2/15/202231,700 shares $137,578.00 +40.3%0.4%0.3 $4.34 1/31/202222,600 shares $110,740.00 -31.3%0.3%0.2 $4.90 1/15/202232,900 shares $216,482.00 +22.3%0.4%0.2 $6.58 12/31/202126,900 shares $185,610.00 -12.7%0.3%0.1 $6.90 12/15/202130,800 shares $224,224.00 -1.3%0.4%0.2 $7.28 11/30/202131,200 shares $288,600.00 -37.2%0.4%0.2 $9.25 11/15/202149,700 shares $506,940.00 -21.2%0.6%0.3 $10.20 10/29/202163,100 shares $633,984.63 +444.0%0.7%0.4 $10.05 10/15/202111,600 shares $105,444.00 -42.3%0.1%0.1 $9.09 9/30/202120,100 shares $222,708.00 -52.4%0.2%0.2 $11.08 9/15/202142,200 shares $531,720.00 -48.9%0.5%0.3 $12.60 8/31/202182,600 shares $1.21 million +140.1%1.0%0.3 $14.67 8/13/202134,400 shares $510,496.00 No Change0.4%0.1 $14.84 CMMB Short Interest - Frequently Asked Questions What is Chemomab Therapeutics' current short interest? Short interest is the volume of Chemomab Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 134,700 shares of CMMB short. 0.81% of Chemomab Therapeutics' shares are currently sold short. Learn More on Chemomab Therapeutics' current short interest. What is a good short interest percentage for Chemomab Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Chemomab Therapeutics' floating shares are currently sold short. Is Chemomab Therapeutics' short interest increasing or decreasing? Chemomab Therapeutics saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 134,700 shares, a decrease of 47.4% from the previous total of 255,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Chemomab Therapeutics' float size? Chemomab Therapeutics currently has issued a total of 14,359,000 shares. Some of Chemomab Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Chemomab Therapeutics currently has a public float of 16,570,000 shares. How does Chemomab Therapeutics' short interest compare to its competitors? 0.81% of Chemomab Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Chemomab Therapeutics: Pyxis Oncology, Inc. (16.29%), Seres Therapeutics, Inc. (11.98%), Biomea Fusion, Inc. (29.36%), Acumen Pharmaceuticals, Inc. (3.97%), Renovaro Inc. (6.62%), Inozyme Pharma, Inc. (10.15%), vTv Therapeutics Inc. (1.55%), Rani Therapeutics Holdings, Inc. (10.27%), Alto Neuroscience, Inc. (14.14%), Metagenomi, Inc. (12.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Chemomab Therapeutics stock? Short selling CMMB is an investing strategy that aims to generate trading profit from Chemomab Therapeutics as its price is falling. CMMB shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Chemomab Therapeutics? A short squeeze for Chemomab Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMMB, which in turn drives the price of the stock up even further. How often is Chemomab Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMMB, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Pyxis Oncology Short Interest Data Seres Therapeutics Short Interest Data Biomea Fusion Short Interest Data Acumen Pharmaceuticals Short Interest Data Renovaro Short Interest Data Inozyme Pharma Short Interest Data vTv Therapeutics Short Interest Data Rani Therapeutics Short Interest Data Alto Neuroscience Short Interest Data Metagenomi Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMMB) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMMB Stock Free CMMB Stock Alerts